Portfolio

LSP Dementia

Investments range between EUR 2 million and EUR 12 million

LSP Dementia seeks to invest in innovative companies focusing on neurodegenerative diseases with dementia, that have products or technologies that target underlying neurodegenerative processes or its symptoms and signs. LSP Dementia’s geographical focus is primarily Europe, but Asia, Israel and the USA are certainly also of interest.

LSP Advisory B.V.
Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands

Company Registration Number: 34296447

LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.

Fast facts

  • Status
    Active
  • Launch
    2020
  • Size
    EUR 160 m

Investment advisory committee

  • Chairperson
    Prof. dr Huibert Pols, emiritus Professor of Internal Medicine
  • Nobi
  • Muna Therapeutics
  • AviadoBio
  • New Amsterdam Pharma

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180